Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
amyloidosis
MedTech
Ultromics nets $55M for its AI cardiac ultrasound software
Ultromics has raised $55 million in venture capital to expand the reach of its AI-powered ultrasound diagnostics for hidden cardiac conditions.
Conor Hale
Aug 4, 2025 10:40am
AstraZeneca amyloidosis drug fails to reduce mortality in ph. 3
Jul 16, 2025 4:28am
Prothena lays off 63% in fallout from phase 3 amyloidosis fail
Jun 20, 2025 2:23am
Prothena reburies drug after 2nd swing at rare disease misses
May 27, 2025 3:33am
Intellia doesn't need to re-dose NTLA-2001. But it can be done
Jun 25, 2024 3:31pm
Anumana's Pfizer-backed AI algorithm nabs FDA breakthrough tag
Jun 22, 2023 10:29am